These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7936281)

  • 1. Levodopa failure in chronic manganism.
    Lu CS; Huang CC; Chu NS; Calne DB
    Neurology; 1994 Sep; 44(9):1600-2. PubMed ID: 7936281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganism and idiopathic parkinsonism: similarities and differences.
    Calne DB; Chu NS; Huang CC; Lu CS; Olanow W
    Neurology; 1994 Sep; 44(9):1583-6. PubMed ID: 7936278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression after chronic manganese exposure.
    Huang CC; Lu CS; Chu NS; Hochberg F; Lilienfeld D; Olanow W; Calne DB
    Neurology; 1993 Aug; 43(8):1479-83. PubMed ID: 8351000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese neurotoxicity: a review of clinical features, imaging and pathology.
    Pal PK; Samii A; Calne DB
    Neurotoxicology; 1999; 20(2-3):227-38. PubMed ID: 10385886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of levodopa treatment for parkinsonism in welders: a double-blind study.
    Chu NS
    Neurology; 2004 Oct; 63(8):1541; author reply 1541. PubMed ID: 15505194
    [No Abstract]   [Full Text] [Related]  

  • 6. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
    Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F
    Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of levodopa treatment for parkinsonism in welders: A double-blind study.
    Koller WC; Lyons KE; Truly W
    Neurology; 2004 Mar; 62(5):730-3. PubMed ID: 15007122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa, manganese, and degenerations of the brain.
    Cotzias GC
    Harvey Lect; 1974; 68():115-47. PubMed ID: 4452625
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopaminergic effects on encoding of a motor memory in chronic stroke.
    Floel A; Hummel F; Breitenstein C; Knecht S; Cohen LG
    Neurology; 2005 Aug; 65(3):472-4. PubMed ID: 16087920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occupational neurotoxicology due to heavy metals-especially manganese poisoning].
    Inoue N
    Brain Nerve; 2007 Jun; 59(6):581-9. PubMed ID: 17585589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind carbidopa/levodopa and placebo study in tardive dyskinesia.
    Simpson GM; Yadalam KG; Stephanos MJ
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):49S-51S. PubMed ID: 2906069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diphenylhydantoin. Blocking of levodopa effects.
    Mendez JS; Cotzias GC; Mena I; Papavasiliou PS
    Arch Neurol; 1975 Jan; 32(1):44-6. PubMed ID: 123156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI; Mark MH
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor function in the normal aging population: treatment with levodopa.
    Newman RP; LeWitt PA; Jaffe M; Calne DB; Larsen TA
    Neurology; 1985 Apr; 35(4):571-3. PubMed ID: 3982646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopa-responsive camptocormia in a patient with multiple system atrophy.
    Song IU; Kim JS; Lee KS
    Parkinsonism Relat Disord; 2008; 14(2):161-3. PubMed ID: 17433754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute pharmacologic blockade of dyskinesias in Parkinson's disease.
    Blanchet PJ; Metman LV; Mouradian MM; Chase TN
    Mov Disord; 1996 Sep; 11(5):580-1. PubMed ID: 8866502
    [No Abstract]   [Full Text] [Related]  

  • 18. Levodopa therapy improves motor function in HIV-infected children with extrapyramidal syndromes.
    Mintz M; Tardieu M; Hoyt L; McSherry G; Mendelson J; Oleske J
    Neurology; 1996 Dec; 47(6):1583-5. PubMed ID: 8960752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa improves procedural motor learning in chronic stroke patients.
    Rösser N; Heuschmann P; Wersching H; Breitenstein C; Knecht S; Flöel A
    Arch Phys Med Rehabil; 2008 Sep; 89(9):1633-41. PubMed ID: 18760148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.
    Hely MA; Morris JG; Reid WG; O'Sullivan DJ; Williamson PM; Rail D; Broe GA; Margrie S
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):903-10. PubMed ID: 8057111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.